Summary

Summary

According to APO Research, the global Veterinary Biologics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Veterinary Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Veterinary Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Veterinary Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Veterinary Biologics include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, DHN, Elanco/Eli Lilly and FATRO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Biologics.

The report will help the Veterinary Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Veterinary Biologics market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Veterinary Biologics Segment by Company

Avimex Animal
Bio-Labs
Boehringer Ingelheim
CAHIC
CAVAC
Ceva
DHN
Elanco/Eli Lilly
FATRO
HVRI
Kyoto Biken
Ringpu Biology
Vaksindo
Virbac
WINSUN
Yebio
Zoetis
ChengDu Tecbond
Jinyu Bio-Technology
Merck

Veterinary Biologics Segment by Type
Vaccines
Monoclonal Antibodies

Veterinary Biologics Segment by Application
Llivestock
Equine
Other

Veterinary Biologics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Biologics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources

2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Biologics Market Size (2020-2031)
2.2.2 Global Veterinary Biologics Sales (2020-2031)
2.2.3 Global Veterinary Biologics Market Average Price (2020-2031)
2.3 Veterinary Biologics by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Vaccines
2.3.3 Monoclonal Antibodies
2.4 Veterinary Biologics by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Llivestock
2.4.3 Equine
2.4.4 Other

3 Market Competitive Landscape by Manufacturers
3.1 Global Veterinary Biologics Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Veterinary Biologics Sales (M Units) of Manufacturers (2020-2025)
3.3 Global Veterinary Biologics Revenue of Manufacturers (2020-2025)
3.4 Global Veterinary Biologics Average Price by Manufacturers (2020-2025)
3.5 Global Veterinary Biologics Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Biologics, Product Type & Application
3.8 Global Manufacturers of Veterinary Biologics, Established Date
3.9 Global Veterinary Biologics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 Manufacturers Profiled
4.1 Avimex Animal
4.1.1 Avimex Animal Company Information
4.1.2 Avimex Animal Business Overview
4.1.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Avimex Animal Veterinary Biologics Product Portfolio
4.1.5 Avimex Animal Recent Developments
4.2 Bio-Labs
4.2.1 Bio-Labs Company Information
4.2.2 Bio-Labs Business Overview
4.2.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Bio-Labs Veterinary Biologics Product Portfolio
4.2.5 Bio-Labs Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 CAHIC
4.4.1 CAHIC Company Information
4.4.2 CAHIC Business Overview
4.4.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.4.4 CAHIC Veterinary Biologics Product Portfolio
4.4.5 CAHIC Recent Developments
4.5 CAVAC
4.5.1 CAVAC Company Information
4.5.2 CAVAC Business Overview
4.5.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.5.4 CAVAC Veterinary Biologics Product Portfolio
4.5.5 CAVAC Recent Developments
4.6 Ceva
4.6.1 Ceva Company Information
4.6.2 Ceva Business Overview
4.6.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Ceva Veterinary Biologics Product Portfolio
4.6.5 Ceva Recent Developments
4.7 DHN
4.7.1 DHN Company Information
4.7.2 DHN Business Overview
4.7.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.7.4 DHN Veterinary Biologics Product Portfolio
4.7.5 DHN Recent Developments
4.8 Elanco/Eli Lilly
4.8.1 Elanco/Eli Lilly Company Information
4.8.2 Elanco/Eli Lilly Business Overview
4.8.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
4.8.5 Elanco/Eli Lilly Recent Developments
4.9 FATRO
4.9.1 FATRO Company Information
4.9.2 FATRO Business Overview
4.9.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.9.4 FATRO Veterinary Biologics Product Portfolio
4.9.5 FATRO Recent Developments
4.10 HVRI
4.10.1 HVRI Company Information
4.10.2 HVRI Business Overview
4.10.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.10.4 HVRI Veterinary Biologics Product Portfolio
4.10.5 HVRI Recent Developments
4.11 Kyoto Biken
4.11.1 Kyoto Biken Company Information
4.11.2 Kyoto Biken Business Overview
4.11.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Kyoto Biken Veterinary Biologics Product Portfolio
4.11.5 Kyoto Biken Recent Developments
4.12 Ringpu Biology
4.12.1 Ringpu Biology Company Information
4.12.2 Ringpu Biology Business Overview
4.12.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Ringpu Biology Veterinary Biologics Product Portfolio
4.12.5 Ringpu Biology Recent Developments
4.13 Vaksindo
4.13.1 Vaksindo Company Information
4.13.2 Vaksindo Business Overview
4.13.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Vaksindo Veterinary Biologics Product Portfolio
4.13.5 Vaksindo Recent Developments
4.14 Virbac
4.14.1 Virbac Company Information
4.14.2 Virbac Business Overview
4.14.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Virbac Veterinary Biologics Product Portfolio
4.14.5 Virbac Recent Developments
4.15 WINSUN
4.15.1 WINSUN Company Information
4.15.2 WINSUN Business Overview
4.15.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.15.4 WINSUN Veterinary Biologics Product Portfolio
4.15.5 WINSUN Recent Developments
4.16 Yebio
4.16.1 Yebio Company Information
4.16.2 Yebio Business Overview
4.16.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Yebio Veterinary Biologics Product Portfolio
4.16.5 Yebio Recent Developments
4.17 Zoetis
4.17.1 Zoetis Company Information
4.17.2 Zoetis Business Overview
4.17.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Zoetis Veterinary Biologics Product Portfolio
4.17.5 Zoetis Recent Developments
4.18 ChengDu Tecbond
4.18.1 ChengDu Tecbond Company Information
4.18.2 ChengDu Tecbond Business Overview
4.18.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.18.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
4.18.5 ChengDu Tecbond Recent Developments
4.19 Jinyu Bio-Technology
4.19.1 Jinyu Bio-Technology Company Information
4.19.2 Jinyu Bio-Technology Business Overview
4.19.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
4.19.5 Jinyu Bio-Technology Recent Developments
4.20 Merck
4.20.1 Merck Company Information
4.20.2 Merck Business Overview
4.20.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
4.20.4 Merck Veterinary Biologics Product Portfolio
4.20.5 Merck Recent Developments

5 Global Veterinary Biologics Market Scenario by Region
5.1 Global Veterinary Biologics Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Veterinary Biologics Sales by Region: 2020-2031
5.2.1 Global Veterinary Biologics Sales by Region: 2020-2025
5.2.2 Global Veterinary Biologics Sales by Region: 2026-2031
5.3 Global Veterinary Biologics Revenue by Region: 2020-2031
5.3.1 Global Veterinary Biologics Revenue by Region: 2020-2025
5.3.2 Global Veterinary Biologics Revenue by Region: 2026-2031
5.4 North America Veterinary Biologics Market Facts & Figures by Country
5.4.1 North America Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Veterinary Biologics Sales by Country (2020-2031)
5.4.3 North America Veterinary Biologics Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Veterinary Biologics Market Facts & Figures by Country
5.5.1 Europe Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Veterinary Biologics Sales by Country (2020-2031)
5.5.3 Europe Veterinary Biologics Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Veterinary Biologics Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Veterinary Biologics Sales by Country (2020-2031)
5.6.3 Asia Pacific Veterinary Biologics Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Veterinary Biologics Market Facts & Figures by Country
5.7.1 South America Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Veterinary Biologics Sales by Country (2020-2031)
5.7.3 South America Veterinary Biologics Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.7.7 Colombia
5.8 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Veterinary Biologics Sales by Country (2020-2031)
5.8.3 Middle East and Africa Veterinary Biologics Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE

6 Segment by Type
6.1 Global Veterinary Biologics Sales by Type (2020-2031)
6.1.1 Global Veterinary Biologics Sales by Type (2020-2031) & (M Units)
6.1.2 Global Veterinary Biologics Sales Market Share by Type (2020-2031)
6.2 Global Veterinary Biologics Revenue by Type (2020-2031)
6.2.1 Global Veterinary Biologics Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Veterinary Biologics Revenue Market Share by Type (2020-2031)
6.3 Global Veterinary Biologics Price by Type (2020-2031)

7 Segment by Application
7.1 Global Veterinary Biologics Sales by Application (2020-2031)
7.1.1 Global Veterinary Biologics Sales by Application (2020-2031) & (M Units)
7.1.2 Global Veterinary Biologics Sales Market Share by Application (2020-2031)
7.2 Global Veterinary Biologics Revenue by Application (2020-2031)
7.2.1 Global Veterinary Biologics Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Veterinary Biologics Revenue Market Share by Application (2020-2031)
7.3 Global Veterinary Biologics Price by Application (2020-2031)

8 Value Chain and Sales Channels Analysis of the Market
8.1 Veterinary Biologics Value Chain Analysis
8.1.1 Veterinary Biologics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Biologics Production Mode & Process
8.2 Veterinary Biologics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Biologics Distributors
8.2.3 Veterinary Biologics Customers

9 Global Veterinary Biologics Analyzing Market Dynamics
9.1 Veterinary Biologics Industry Trends
9.2 Veterinary Biologics Industry Drivers
9.3 Veterinary Biologics Industry Opportunities and Challenges
9.4 Veterinary Biologics Industry Restraints

10 Report Conclusion
11 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Veterinary Biologics Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Veterinary Biologics Sales (M Units) of Manufacturers (2020-2025)
Table 7. Global Veterinary Biologics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Veterinary Biologics Revenue of Manufacturers (2020-2025)
Table 9. Global Veterinary Biologics Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Veterinary Biologics Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Veterinary Biologics Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Veterinary Biologics, Product Type & Application
Table 14. Global Veterinary Biologics Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Veterinary Biologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Avimex Animal Company Information
Table 19. Avimex Animal Business Overview
Table 20. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. Avimex Animal Veterinary Biologics Product Portfolio
Table 22. Avimex Animal Recent Developments
Table 23. Bio-Labs Company Information
Table 24. Bio-Labs Business Overview
Table 25. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. Bio-Labs Veterinary Biologics Product Portfolio
Table 27. Bio-Labs Recent Developments
Table 28. Boehringer Ingelheim Company Information
Table 29. Boehringer Ingelheim Business Overview
Table 30. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. Boehringer Ingelheim Veterinary Biologics Product Portfolio
Table 32. Boehringer Ingelheim Recent Developments
Table 33. CAHIC Company Information
Table 34. CAHIC Business Overview
Table 35. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. CAHIC Veterinary Biologics Product Portfolio
Table 37. CAHIC Recent Developments
Table 38. CAVAC Company Information
Table 39. CAVAC Business Overview
Table 40. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. CAVAC Veterinary Biologics Product Portfolio
Table 42. CAVAC Recent Developments
Table 43. Ceva Company Information
Table 44. Ceva Business Overview
Table 45. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 46. Ceva Veterinary Biologics Product Portfolio
Table 47. Ceva Recent Developments
Table 48. DHN Company Information
Table 49. DHN Business Overview
Table 50. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 51. DHN Veterinary Biologics Product Portfolio
Table 52. DHN Recent Developments
Table 53. Elanco/Eli Lilly Company Information
Table 54. Elanco/Eli Lilly Business Overview
Table 55. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Elanco/Eli Lilly Veterinary Biologics Product Portfolio
Table 57. Elanco/Eli Lilly Recent Developments
Table 58. FATRO Company Information
Table 59. FATRO Business Overview
Table 60. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 61. FATRO Veterinary Biologics Product Portfolio
Table 62. FATRO Recent Developments
Table 63. HVRI Company Information
Table 64. HVRI Business Overview
Table 65. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. HVRI Veterinary Biologics Product Portfolio
Table 67. HVRI Recent Developments
Table 68. Kyoto Biken Company Information
Table 69. Kyoto Biken Business Overview
Table 70. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 71. Kyoto Biken Veterinary Biologics Product Portfolio
Table 72. Kyoto Biken Recent Developments
Table 73. Ringpu Biology Company Information
Table 74. Ringpu Biology Business Overview
Table 75. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Ringpu Biology Veterinary Biologics Product Portfolio
Table 77. Ringpu Biology Recent Developments
Table 78. Vaksindo Company Information
Table 79. Vaksindo Business Overview
Table 80. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vaksindo Veterinary Biologics Product Portfolio
Table 82. Vaksindo Recent Developments
Table 83. Virbac Company Information
Table 84. Virbac Business Overview
Table 85. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Virbac Veterinary Biologics Product Portfolio
Table 87. Virbac Recent Developments
Table 88. WINSUN Company Information
Table 89. WINSUN Business Overview
Table 90. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. WINSUN Veterinary Biologics Product Portfolio
Table 92. WINSUN Recent Developments
Table 93. Yebio Company Information
Table 94. Yebio Business Overview
Table 95. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Yebio Veterinary Biologics Product Portfolio
Table 97. Yebio Recent Developments
Table 98. Zoetis Company Information
Table 99. Zoetis Business Overview
Table 100. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Zoetis Veterinary Biologics Product Portfolio
Table 102. Zoetis Recent Developments
Table 103. ChengDu Tecbond Company Information
Table 104. ChengDu Tecbond Business Overview
Table 105. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. ChengDu Tecbond Veterinary Biologics Product Portfolio
Table 107. ChengDu Tecbond Recent Developments
Table 108. Jinyu Bio-Technology Company Information
Table 109. Jinyu Bio-Technology Business Overview
Table 110. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Jinyu Bio-Technology Veterinary Biologics Product Portfolio
Table 112. Jinyu Bio-Technology Recent Developments
Table 113. Merck Company Information
Table 114. Merck Business Overview
Table 115. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Merck Veterinary Biologics Product Portfolio
Table 117. Merck Recent Developments
Table 118. Global Veterinary Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 119. Global Veterinary Biologics Sales by Region (2020-2025) & (M Units)
Table 120. Global Veterinary Biologics Sales Market Share by Region (2020-2025)
Table 121. Global Veterinary Biologics Sales by Region (2026-2031) & (M Units)
Table 122. Global Veterinary Biologics Sales Market Share by Region (2026-2031)
Table 123. Global Veterinary Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 124. Global Veterinary Biologics Revenue Market Share by Region (2020-2025)
Table 125. Global Veterinary Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 126. Global Veterinary Biologics Revenue Market Share by Region (2026-2031)
Table 127. North America Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 128. North America Veterinary Biologics Sales by Country (2020-2025) & (M Units)
Table 129. North America Veterinary Biologics Sales by Country (2026-2031) & (M Units)
Table 130. North America Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 131. North America Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 133. Europe Veterinary Biologics Sales by Country (2020-2025) & (M Units)
Table 134. Europe Veterinary Biologics Sales by Country (2026-2031) & (M Units)
Table 135. Europe Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 136. Europe Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 137. Asia Pacific Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 138. Asia Pacific Veterinary Biologics Sales by Country (2020-2025) & (M Units)
Table 139. Asia Pacific Veterinary Biologics Sales by Country (2026-2031) & (M Units)
Table 140. Asia Pacific Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 141. Asia Pacific Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 142. South America Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 143. South America Veterinary Biologics Sales by Country (2020-2025) & (M Units)
Table 144. South America Veterinary Biologics Sales by Country (2026-2031) & (M Units)
Table 145. South America Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 146. South America Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 147. Middle East and Africa Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 148. Middle East and Africa Veterinary Biologics Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Veterinary Biologics Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 152. Global Veterinary Biologics Sales by Type (2020-2025) & (M Units)
Table 153. Global Veterinary Biologics Sales by Type (2026-2031) & (M Units)
Table 154. Global Veterinary Biologics Sales Market Share by Type (2020-2025)
Table 155. Global Veterinary Biologics Sales Market Share by Type (2026-2031)
Table 156. Global Veterinary Biologics Revenue by Type (2020-2025) & (US$ Million)
Table 157. Global Veterinary Biologics Revenue by Type (2026-2031) & (US$ Million)
Table 158. Global Veterinary Biologics Revenue Market Share by Type (2020-2025)
Table 159. Global Veterinary Biologics Revenue Market Share by Type (2026-2031)
Table 160. Global Veterinary Biologics Price by Type (2020-2025) & (US$/Unit)
Table 161. Global Veterinary Biologics Price by Type (2026-2031) & (US$/Unit)
Table 162. Global Veterinary Biologics Sales by Application (2020-2025) & (M Units)
Table 163. Global Veterinary Biologics Sales by Application (2026-2031) & (M Units)
Table 164. Global Veterinary Biologics Sales Market Share by Application (2020-2025)
Table 165. Global Veterinary Biologics Sales Market Share by Application (2026-2031)
Table 166. Global Veterinary Biologics Revenue by Application (2020-2025) & (US$ Million)
Table 167. Global Veterinary Biologics Revenue by Application (2026-2031) & (US$ Million)
Table 168. Global Veterinary Biologics Revenue Market Share by Application (2020-2025)
Table 169. Global Veterinary Biologics Revenue Market Share by Application (2026-2031)
Table 170. Global Veterinary Biologics Price by Application (2020-2025) & (US$/Unit)
Table 171. Global Veterinary Biologics Price by Application (2026-2031) & (US$/Unit)
Table 172. Key Raw Materials
Table 173. Raw Materials Key Suppliers
Table 174. Veterinary Biologics Distributors List
Table 175. Veterinary Biologics Customers List
Table 176. Veterinary Biologics Industry Trends
Table 177. Veterinary Biologics Industry Drivers
Table 178. Veterinary Biologics Industry Restraints
Table 179. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary Biologics Product Image
Figure 5. Global Veterinary Biologics Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Veterinary Biologics Market Size (2020-2031) & (US$ Million)
Figure 7. Global Veterinary Biologics Sales (2020-2031) & (M Units)
Figure 8. Global Veterinary Biologics Average Price (US$/Unit) & (2020-2031)
Figure 9. Vaccines Product Image
Figure 10. Monoclonal Antibodies Product Image
Figure 11. Llivestock Product Image
Figure 12. Equine Product Image
Figure 13. Other Product Image
Figure 14. Global Veterinary Biologics Revenue Share by Manufacturers in 2024
Figure 15. Global Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Veterinary Biologics Players Market Share by Revenue in 2024
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 18. Global Veterinary Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 19. Global Veterinary Biologics Sales by Region in 2024
Figure 20. Global Veterinary Biologics Revenue by Region in 2024
Figure 21. North America Veterinary Biologics Market Size by Country in 2024
Figure 22. North America Veterinary Biologics Sales Market Share by Country (2020-2031)
Figure 23. North America Veterinary Biologics Revenue Market Share by Country (2020-2031)
Figure 24. United States Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Veterinary Biologics Market Size by Country in 2024
Figure 27. Europe Veterinary Biologics Sales Market Share by Country (2020-2031)
Figure 28. Europe Veterinary Biologics Revenue Market Share by Country (2020-2031)
Figure 29. Germany Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Netherlands Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Veterinary Biologics Market Size by Country in 2024
Figure 35. Asia Pacific Veterinary Biologics Sales Market Share by Country (2020-2031)
Figure 36. Asia Pacific Veterinary Biologics Revenue Market Share by Country (2020-2031)
Figure 37. China Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South America Veterinary Biologics Market Size by Country in 2024
Figure 46. South America Veterinary Biologics Sales Market Share by Country (2020-2031)
Figure 47. South America Veterinary Biologics Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Veterinary Biologics Market Size by Country in 2024
Figure 53. Middle East and Africa Veterinary Biologics Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Veterinary Biologics Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Veterinary Biologics Sales Market Share by Type (2020-2031)
Figure 59. Global Veterinary Biologics Revenue Market Share by Type (2020-2031)
Figure 60. Global Veterinary Biologics Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Veterinary Biologics Sales Market Share by Application (2020-2031)
Figure 62. Global Veterinary Biologics Revenue Market Share by Application (2020-2031)
Figure 63. Global Veterinary Biologics Price (US$/Unit) by Application (2020-2031)
Figure 64. Veterinary Biologics Value Chain
Figure 65. Veterinary Biologics Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Veterinary Biologics Industry Opportunities and Challenges